ICAD
ICAD Inc
Price:  
1.97 
USD
Volume:  
342,029.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ICAD EV/EBITDA

-203.2%
Upside

As of 2024-12-14, the EV/EBITDA ratio of ICAD Inc (ICAD) is -6.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICAD's latest enterprise value is 33.49 mil USD. ICAD's TTM EBITDA according to its financial statements is -5.30 mil USD. Dividing these 2 quantities gives us the above ICAD EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 4.3x - 17.7x 10.9x
Forward P/E multiples 10.1x - 22.5x 16.6x
Fair Price (1.31) - (2.83) (2.03)
Upside -166.3% - -243.5% -203.2%
1.97 USD
Stock Price
(2.03) USD
Fair Price

ICAD EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-11 -6.32
2024-12-10 -5.92
2024-12-09 -5.87
2024-12-06 -5.17
2024-12-05 -4.87
2024-12-04 -4.97
2024-12-03 -4.97
2024-12-02 -5.27
2024-11-29 -5.12
2024-11-27 -5.32
2024-11-26 -5.12
2024-11-25 -4.37
2024-11-22 -4.16
2024-11-21 -4.16
2024-11-20 -4.19
2024-11-19 -4.27
2024-11-18 -4.06
2024-11-15 -4.67
2024-11-14 -5.39
2024-11-13 -8.17
2024-11-12 -8.47
2024-11-11 -7.02
2024-11-08 -7.12
2024-11-07 -5.92
2024-11-06 -5.77
2024-11-05 -5.42
2024-11-04 -5.17
2024-11-01 -5.57
2024-10-31 -5.77
2024-10-30 -5.72
2024-10-29 -5.97
2024-10-28 -6.12
2024-10-25 -6.27
2024-10-24 -5.82
2024-10-23 -5.22
2024-10-22 -5.27
2024-10-21 -5.57
2024-10-18 -5.92
2024-10-17 -6.22
2024-10-16 -6.22
2024-10-15 -4.42
2024-10-14 -4.11
2024-10-11 -3.76
2024-10-10 -3.41
2024-10-09 -3.71
2024-10-08 -4.09
2024-10-07 -4.27
2024-10-04 -4.27
2024-10-03 -4.11
2024-10-02 -4.52